-
1
-
-
12644276375
-
A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening
-
Chen Y.T., Scanlan M.J., Sahin U., Türeci O., Gure A.O., Tsang S., et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 1997, 94:1914-1918.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 1914-1918
-
-
Chen, Y.T.1
Scanlan, M.J.2
Sahin, U.3
Türeci, O.4
Gure, A.O.5
Tsang, S.6
-
2
-
-
23144464171
-
Cancer/testis antigens, gametogenesis and cancer
-
Simpson A.J., Caballero O.L., Jungbluth A., Chen Y.T., Old L.J. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer 2005, 5:615-625.
-
(2005)
Nat Rev Cancer
, vol.5
, pp. 615-625
-
-
Simpson, A.J.1
Caballero, O.L.2
Jungbluth, A.3
Chen, Y.T.4
Old, L.J.5
-
3
-
-
33746211234
-
NY-ESO-1: review of an immunogenic tumor antigen
-
Gnjatic S., Nishikawa H., Jungbluth A.A., Güre A.O., Ritter G., Jäger E., et al. NY-ESO-1: review of an immunogenic tumor antigen. Adv Cancer Res 2006, 95:1-30.
-
(2006)
Adv Cancer Res
, vol.95
, pp. 1-30
-
-
Gnjatic, S.1
Nishikawa, H.2
Jungbluth, A.A.3
Güre, A.O.4
Ritter, G.5
Jäger, E.6
-
4
-
-
0035876940
-
Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues
-
Jungbluth A.A., Chen Y.T., Stockert E., Busam K.J., Kolb D., Iversen K., et al. Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer 2001, 92:856-860.
-
(2001)
Int J Cancer
, vol.92
, pp. 856-860
-
-
Jungbluth, A.A.1
Chen, Y.T.2
Stockert, E.3
Busam, K.J.4
Kolb, D.5
Iversen, K.6
-
5
-
-
2642673605
-
A survey of the humoral immune response of cancer patients to a panel of human tumor antigens
-
Stockert E., Jäger E., Chen Y.T., Scanlan M.J., Gout I., Karbach J., et al. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med 1998, 187:1349-1354.
-
(1998)
J Exp Med
, vol.187
, pp. 1349-1354
-
-
Stockert, E.1
Jäger, E.2
Chen, Y.T.3
Scanlan, M.J.4
Gout, I.5
Karbach, J.6
-
6
-
-
0033595632
-
Humoral immune responses of cancer patients against " Cancer-Testis" antigen NY-ESO-1: correlation with clinical events
-
Jäger E., Stockert E., Zidianakis Z., Chen Y.T., Karbach J., Jäger D., et al. Humoral immune responses of cancer patients against " Cancer-Testis" antigen NY-ESO-1: correlation with clinical events. Int J Cancer 1999, 84:506-510.
-
(1999)
Int J Cancer
, vol.84
, pp. 506-510
-
-
Jäger, E.1
Stockert, E.2
Zidianakis, Z.3
Chen, Y.T.4
Karbach, J.5
Jäger, D.6
-
7
-
-
0041305899
-
Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses
-
Gnjatic S., Atanackovic D., Jäger E., Matsuo M., Selvakumar A., Altorki N.K., et al. Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses. Proc Natl Acad Sci USA 2003, 100:8862-8867.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 8862-8867
-
-
Gnjatic, S.1
Atanackovic, D.2
Jäger, E.3
Matsuo, M.4
Selvakumar, A.5
Altorki, N.K.6
-
8
-
-
0038691976
-
Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses
-
Jäger E., Nagata Y., Gnjatic S., Wada H., Stockert E., Karbach J., et al. Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. Proc Natl Acad Sci USA 2000, 97:4760-4765.
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 4760-4765
-
-
Jäger, E.1
Nagata, Y.2
Gnjatic, S.3
Wada, H.4
Stockert, E.5
Karbach, J.6
-
9
-
-
33646083008
-
Directions in the immune targeting of cancer: lessons learned from the cancer-testis Ag NY-ESO-1
-
Nicholaou T., Ebert L., Davis I.D., Robson N., Klein O., Maraskovsky E., et al. Directions in the immune targeting of cancer: lessons learned from the cancer-testis Ag NY-ESO-1. Immunol Cell Biol 2006, 84:303-307.
-
(2006)
Immunol Cell Biol
, vol.84
, pp. 303-307
-
-
Nicholaou, T.1
Ebert, L.2
Davis, I.D.3
Robson, N.4
Klein, O.5
Maraskovsky, E.6
-
10
-
-
3242658810
-
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans
-
Davis I.D., Chen W., Jackson H., Parente P., Shackleton M., Hopkins W., et al. Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans. Proc Natl Acad Sci USA 2004, 101:10697-10702.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 10697-10702
-
-
Davis, I.D.1
Chen, W.2
Jackson, H.3
Parente, P.4
Shackleton, M.5
Hopkins, W.6
-
11
-
-
34247485458
-
T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein
-
Uenaka A., Wada H., Isobe M., Saika T., Tsuji K., Sato E., et al. T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein. Cancer Immun 2007, 7:9.
-
(2007)
Cancer Immun
, vol.7
, pp. 9
-
-
Uenaka, A.1
Wada, H.2
Isobe, M.3
Saika, T.4
Tsuji, K.5
Sato, E.6
-
12
-
-
34547475142
-
Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming
-
Valmori D., Souleimanian N.E., Tosello V., Bhardwaj N., Adams S., O'Neill D., et al. Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming. Proc Natl Acad Sci USA 2007, 104:8947-8952.
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 8947-8952
-
-
Valmori, D.1
Souleimanian, N.E.2
Tosello, V.3
Bhardwaj, N.4
Adams, S.5
O'Neill, D.6
-
13
-
-
47949129948
-
Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant
-
Adams S., O'Neill D.W., Nonaka D., Hardin E., Chiriboga L., Siu K., et al. Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant. J Immunol 2008, 181:776-784.
-
(2008)
J Immunol
, vol.181
, pp. 776-784
-
-
Adams, S.1
O'Neill, D.W.2
Nonaka, D.3
Hardin, E.4
Chiriboga, L.5
Siu, K.6
-
14
-
-
33749237126
-
Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients
-
Jäger E., Karbach J., Gnjatic S., Neumann A., Bender A., Valmori D., et al. Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients. Proc Natl Acad Sci USA 2006, 103:14453-14458.
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 14453-14458
-
-
Jäger, E.1
Karbach, J.2
Gnjatic, S.3
Neumann, A.4
Bender, A.5
Valmori, D.6
-
15
-
-
34147101570
-
Antibody response against NY-ESO-1 in CHP-NY-ESO-1 vaccinated patients
-
Kawabata R., Wada H., Isobe M., Saika T., Sato S., Uenaka A., et al. Antibody response against NY-ESO-1 in CHP-NY-ESO-1 vaccinated patients. Int J Cancer 2007, 120:2178-2184.
-
(2007)
Int J Cancer
, vol.120
, pp. 2178-2184
-
-
Kawabata, R.1
Wada, H.2
Isobe, M.3
Saika, T.4
Sato, S.5
Uenaka, A.6
-
16
-
-
48149088825
-
Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient
-
Tsuji K., Hamada T., Uenaka A., Wada H., Sato E., Isobe M., et al. Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient. Cancer Immunol Immunother 2008, 57:1429-1437.
-
(2008)
Cancer Immunol Immunother
, vol.57
, pp. 1429-1437
-
-
Tsuji, K.1
Hamada, T.2
Uenaka, A.3
Wada, H.4
Sato, E.5
Isobe, M.6
-
17
-
-
53449084664
-
Analysis of peripheral and local anti-tumor immune response in esophageal cancer patients after NY-ESO-1 protein vaccination
-
Wada H., Sato E., Uenaka A., Isobe M., Kawabata R., Nakamura Y., et al. Analysis of peripheral and local anti-tumor immune response in esophageal cancer patients after NY-ESO-1 protein vaccination. Int J Cancer 2008, 123:2362-2369.
-
(2008)
Int J Cancer
, vol.123
, pp. 2362-2369
-
-
Wada, H.1
Sato, E.2
Uenaka, A.3
Isobe, M.4
Kawabata, R.5
Nakamura, Y.6
-
18
-
-
20244384857
-
Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditions
-
Murphy R., Green S., Ritter G., Cohen L., Ryan D., Woods W., et al. Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditions. Prep Biochem Biotechnol 2005, 35:119-134.
-
(2005)
Prep Biochem Biotechnol
, vol.35
, pp. 119-134
-
-
Murphy, R.1
Green, S.2
Ritter, G.3
Cohen, L.4
Ryan, D.5
Woods, W.6
-
19
-
-
0028877293
-
Rejection antigen peptides on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes: derivation from the normally untranslated 5'-region of the c-akt proto-oncogene activated by LTR
-
Wada H., Matsuo M., Uenaka A., Shimbara N., Shimizu K., Nakayama E. Rejection antigen peptides on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes: derivation from the normally untranslated 5'-region of the c-akt proto-oncogene activated by LTR. Cancer Res 1995, 55:4780-4783.
-
(1995)
Cancer Res
, vol.55
, pp. 4780-4783
-
-
Wada, H.1
Matsuo, M.2
Uenaka, A.3
Shimbara, N.4
Shimizu, K.5
Nakayama, E.6
-
20
-
-
0035875056
-
NY-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade
-
Kurashige T., Noguchi Y., Saika T., Ono T., Nagata Y., Jungbluth A., et al. NY-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade. Cancer Res 2001, 61:4671-4674.
-
(2001)
Cancer Res
, vol.61
, pp. 4671-4674
-
-
Kurashige, T.1
Noguchi, Y.2
Saika, T.3
Ono, T.4
Nagata, Y.5
Jungbluth, A.6
-
21
-
-
55949114186
-
Use of MHC class II tetramers to investigate CD4+ T cell responses: problems and solutions
-
Cecconi V., Moro M., Del Mare S., Dellabona P., Casorati G. Use of MHC class II tetramers to investigate CD4+ T cell responses: problems and solutions. Cytometry A 2008, 73:1010-1018.
-
(2008)
Cytometry A
, vol.73
, pp. 1010-1018
-
-
Cecconi, V.1
Moro, M.2
Del Mare, S.3
Dellabona, P.4
Casorati, G.5
-
22
-
-
0034662263
-
Identification of CD4+ T cell epitopes from NY-ESO-1 presented by HLA-DR molecules
-
Zeng G., Touloukian C.E., Wang X., Restifo N.P., Rosenberg S.A., Wang R.F. Identification of CD4+ T cell epitopes from NY-ESO-1 presented by HLA-DR molecules. J Immunol 2000, 165:1153-1159.
-
(2000)
J Immunol
, vol.165
, pp. 1153-1159
-
-
Zeng, G.1
Touloukian, C.E.2
Wang, X.3
Restifo, N.P.4
Rosenberg, S.A.5
Wang, R.F.6
-
23
-
-
0034282998
-
NY-ESO-1 encodes DRB1*0401-restricted epitopes recognized by melanoma-reactive CD4+ T cells
-
Zarour H.M., Storkus W.J., Brusic V., Williams E., Kirkwood J.M. NY-ESO-1 encodes DRB1*0401-restricted epitopes recognized by melanoma-reactive CD4+ T cells. Cancer Res 2000, 60:4946-4952.
-
(2000)
Cancer Res
, vol.60
, pp. 4946-4952
-
-
Zarour, H.M.1
Storkus, W.J.2
Brusic, V.3
Williams, E.4
Kirkwood, J.M.5
-
24
-
-
34249893960
-
Identification of a novel NY-ESO-1 promiscuous helper epitope presented by multiple MHC class II molecules found frequently in the Japanese population
-
Ohkuri T., Sato M., Abe H., Tsuji K., Yamagishi Y., Ikeda H., et al. Identification of a novel NY-ESO-1 promiscuous helper epitope presented by multiple MHC class II molecules found frequently in the Japanese population. Cancer Sci 2007, 98:1092-1098.
-
(2007)
Cancer Sci
, vol.98
, pp. 1092-1098
-
-
Ohkuri, T.1
Sato, M.2
Abe, H.3
Tsuji, K.4
Yamagishi, Y.5
Ikeda, H.6
-
25
-
-
0034695886
-
Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma
-
Jäger E., Jäger D., Karbach J., Chen Y.T., Ritter G., Nagata Y., et al. Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma. J Exp Med 2000, 191:625-630.
-
(2000)
J Exp Med
, vol.191
, pp. 625-630
-
-
Jäger, E.1
Jäger, D.2
Karbach, J.3
Chen, Y.T.4
Ritter, G.5
Nagata, Y.6
-
26
-
-
12944265542
-
Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele
-
Gnjatic S., Nagata Y., Jager E., Stockert E., Shankara S., Roberts B.L., et al. Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele. Proc Natl Acad Sci USA 2000, 97:10917-10922.
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 10917-10922
-
-
Gnjatic, S.1
Nagata, Y.2
Jager, E.3
Stockert, E.4
Shankara, S.5
Roberts, B.L.6
-
27
-
-
85044704273
-
Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51
-
Jäger E., Karbach J., Gnjatic S., Jäger D., Maeurer M., Atmaca A., et al. Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51. Cancer Immun 2002, 2:12.
-
(2002)
Cancer Immun
, vol.2
, pp. 12
-
-
Jäger, E.1
Karbach, J.2
Gnjatic, S.3
Jäger, D.4
Maeurer, M.5
Atmaca, A.6
-
28
-
-
0345016358
-
Identification of five new HLA-B*3501-restricted epitopes derived from common melanoma-associated antigens, spontaneously recognized by tumor-infiltrating lymphocytes
-
Benlalam H., Linard B., Guilloux Y., Moreau-Aubry A., Derré L., Diez E., et al. Identification of five new HLA-B*3501-restricted epitopes derived from common melanoma-associated antigens, spontaneously recognized by tumor-infiltrating lymphocytes. J Immunol 2003, 171:6283-6289.
-
(2003)
J Immunol
, vol.171
, pp. 6283-6289
-
-
Benlalam, H.1
Linard, B.2
Guilloux, Y.3
Moreau-Aubry, A.4
Derré, L.5
Diez, E.6
-
29
-
-
19944430099
-
One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma
-
Mandic M., Castelli F., Janjic B., Almunia C., Andrade P., Gillet D., et al. One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma. J Immunol 2005, 174:1751-1759.
-
(2005)
J Immunol
, vol.174
, pp. 1751-1759
-
-
Mandic, M.1
Castelli, F.2
Janjic, B.3
Almunia, C.4
Andrade, P.5
Gillet, D.6
-
30
-
-
67650375847
-
Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire
-
Bioley G., Dousset C., Yeh A., Dupont B., Bhardwaj N., Mears G., et al. Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire. Clin Cancer Res 2009, 15:4467-4474.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 4467-4474
-
-
Bioley, G.1
Dousset, C.2
Yeh, A.3
Dupont, B.4
Bhardwaj, N.5
Mears, G.6
-
31
-
-
0036141435
-
NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells
-
Zarour H.M., Maillere B., Brusic V., Coval K., Williams E., Pouvelle-Moratille S., et al. NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells. Cancer Res 2002, 62:213-218.
-
(2002)
Cancer Res
, vol.62
, pp. 213-218
-
-
Zarour, H.M.1
Maillere, B.2
Brusic, V.3
Coval, K.4
Williams, E.5
Pouvelle-Moratille, S.6
-
32
-
-
44249118831
-
Recognition of naturally processed and ovarian cancer reactive CD8+ T cell epitopes within a promiscuous HLA class II T-helper region of NY-ESO-1
-
Matsuzaki J., Qian F., Luescher I., Lele S., Ritter G., Shrikant P.A., et al. Recognition of naturally processed and ovarian cancer reactive CD8+ T cell epitopes within a promiscuous HLA class II T-helper region of NY-ESO-1. Cancer Immunol Immunother 2008, 57:1185-1195.
-
(2008)
Cancer Immunol Immunother
, vol.57
, pp. 1185-1195
-
-
Matsuzaki, J.1
Qian, F.2
Luescher, I.3
Lele, S.4
Ritter, G.5
Shrikant, P.A.6
-
33
-
-
63549100184
-
Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma
-
Nicholaou T., Ebert L.M., Davis I.D., McArthur G.A., Jackson H., Dimopoulos N., et al. Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma. Clin Cancer Res 2009, 15:2166-2173.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 2166-2173
-
-
Nicholaou, T.1
Ebert, L.M.2
Davis, I.D.3
McArthur, G.A.4
Jackson, H.5
Dimopoulos, N.6
|